Research Article
Association of Copper Status with Lipid Profile and Functional Status in Patients with Amyotrophic Lateral Sclerosis
Table 2
Correlation of plasma copper and serum ceruloplasmin with dietary copper and lipid profile of the participants.
| Variable | Case group | Control group | | | value | | | value |
| Plasma copper | | | | | | | Dietary copper | 27 | 0.194 | 0.333 | 23 | 0.054 | 0.807 | Serum ceruloplasmin | 23 | 0.152 | 0.488 | 25 | 0.646 | <0.001 | Total cholesterol | 27 | 0.293 | 0.138 | 25 | 0.446 | 0.025 | LDL-cholesterol | 27 | 0.292 | 0.140 | 24 | 0.445 | 0.029 | HDL-cholesterol | 26 | 0.398 | 0.044 | 25 | 0.479 | 0.015 | Triglycerides | 27 | −0.208 | 0.297 | 25 | 0.371 | 0.068 |
| Serum ceruloplasmin | | | | | | | Dietary copper | 23 | −0.145 | 0.508 | 24 | −0.184 | 0.390 | Total cholesterol | 23 | 0.083 | 0.707 | 26 | 0.320 | 0.110 | LDL-cholesterol | 23 | 0.053 | 0.810 | 25 | 0.407 | 0.043 | HDL-cholesterol | 22 | 0.211 | 0.346 | 26 | 0.254 | 0.210 | Triglycerides | 23 | −0.290 | 0.179 | 26 | 0.134 | 0.515 |
|
|
: Spearman’s correlation coefficient. |